Demonstration that platelet-activating factor is capable of activating mast cells and inducing a chemotactic response

Immunology

Volumn 99, Issue 2, 2000, Pages 314-319

  Nilsson, G ^a   Metcalfe, D D ^b   Taub, D D ^c  

^a UPPSALA UNIVERSITY   (Sweden)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; COMPLEMENT COMPONENT C5A; GUANINE NUCLEOTIDE BINDING PROTEIN; THROMBOCYTE ACTIVATING FACTOR;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CHEMOTAXIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MAST CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; CELL CULTURE TECHNIQUES; CHEMOTAXIS; COMPLEMENT C5A; HUMANS; MAST CELLS; MICE; PERTUSSIS TOXIN; PLATELET ACTIVATING FACTOR; SIGNAL TRANSDUCTION; VIRULENCE FACTORS, BORDETELLA;

EID: 0033961930     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2000.00972.x     Document Type: Article

References (37)

1. 1. Chao W. & Olson M.S. (1993) Platelet-activating factor: receptors and signal transduction. Biochem J 292, 617.
2. 2. Cuss F.M., Dixon C.M.S. & Barnes P.J. (1986) Effects of inhaled platelet-activating factor on pulmonary function and bronchial responsiveness in man. Lancet 8500, 189.
3. 3. Chen C.R., Voekel N.F. & Chang S.W. (1992) Pulmonary vascular reactivity: effect of PAF and PAF antagonists. J Appl Physiol 73, 1762.
4. 4. Shaw J.O., Pinckard R.N., Ferrigni K.S., McManus L.M. & Hanahan DJ. (1981) Activation of human neutrophils with 1-Hexadecyl/octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (platelet activation factor). J Immunol 127, 1250.
5. 5. Wardlaw A.J., Moqbel R., Cromwell O. & Kay A.B. (1986) Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest 78, 1701.
6. 6. Nakamura M., Honda Z., Izumi T. et al. (1991) Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. J Biol Chem 266, 20400.
7. 7. Holgate S.T., Hardy C, Robinson C., Agius R. & Howarth P.H. (1986) The mast cell as a primary effector cell in the pathogenesis of asthma. J Allergy Clin Immunol 77, 274.
8. 8. Nilsson G. & Schwartz L.B. (1995) Mast cell heterogeneity: structure and mediators. In: Asthma and Rhinitis (eds W.W. BUSSE & S.T. Holgate) p. 195. Blackwell Science, Boston.
9. 9. Enerbäck L., Pipkorn U. & Granerus G. (1986) Intraepithelial migration of nasal mucosal mast cells in hay fever. Int Arch Allergy Immunol 80, 44.
10. 10. Godfrey H.P., Ilardi C., Engber W. & Graziano F.M. (1984) Quantification of human synovial mast cells in rheumatoid arthritis and other rheumatic diseases. Arthritis Rheum 27, 852.
11. 11. Gibson P.G., Allen C.J., Yang J.P. et al. (1993) Intraepithelial mast cells in allergic and nonallergic asthma. Assessment using bronchial brushings. Am Rev Respir Dis 148, 80.
12. 12. Nilsson G., Butterfield J.H., Nilsson K. & Siegbahn A. (1994) Stem cell factor is a chemolactic factor for human mast cells. J Immunol 153, 3717.
13. 13. Gruber B.L., Marchese M.J. & Kew R.R. (1994) Transforming growth factor-β1 mediates mast cell chemotaxis. J Immunol 152, 5860.
14. 14. Nilsson G., Johnell M., Hammer C.H. et al. (1996) C3a and C5a are chemotaxins for mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J Immunol 157, 1693.
15. 15. Nilsson G., Mikovits J., Metcalfe D.D. & Taub D.D. (1999) Mast cell migratory response to IL-8 is mediated through interaction with chemokine receptor CXC-2/IL-8RB. Blood 93, 2791.
16. 16. Hartmann K., Henz B.M., Krüger-Krasagakes S. et al. (1997) C3a and C5a stimulate chemotaxis of human mast cells. Blood 89, 2863.
17. 17. Butterfield J.H., Weiler D., Dewald G. & Gleich G.J. (1988) Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 12, 345.
18. 18. Nilsson G., Blom T., Harvima I. et al. (1996) Stem cell factor-dependent human cord blood derived mast cells express α-and β-tryptase, heparin and chondroitin sulphate. Immunology 88, 308.
19. 19. Taub D., Dastych J., Inamura N. et al. (1995) Bone marrow-derived murine mast cells migrate, but do not degranulate, in response to chemokines. J Immunol 154, 2393.
20. 20. Barnes P.J., Chung K.F. & Chung C.P. (1988) Platelet-activating factor as a mediator of allergic diseases. J Allergy Clin Immunol 81, 919.
21. 21. Smith L.J. (1991) The role of platelet-activating factor in asthma. Am Rev Respir Dis 143, S100.
22. 22. Chan-Yeung M., Lam S., Chan H., Tse K.S. & Salari H. (1991) The release of platelet-activating factor into plasma during allergen-induced bronchoconstriction. J Allergy Clin Immunol 87, 667.
23. 23. Laitinen L.A., Laitinen A. & haahtela T. (1993) Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 147, 697.
24. 24. Irani A.A., Nilsson G., Miettinen U. et al. (1992) Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 80, 3009.
25. 25. Thomas G. & Church M.K. (1990) Platelet activating factor does not release histamine from dispersed cutaneous mast cells. Clin Exp Allergy 20, 377.
26. 26. Columbo M., Casolaro V., Warner J.A., Macglashan D.W.J., Kagey-Sobotka A. & Lichtenstein L.M. (1990) The mechanism of mediator release from human basophils induced by platelet-activating factor. J Immunol 145, 3855.
27. 27. Petersen L.J., Church M.K. & Skov P.S. (1997) Platelet-activating factor induces histamine release from human skin mast cells in vivo, which is reduced by local nerve blockade. J Allerg Clin Immunol 99, 640.
28. 28. Amatruda T.T., Gerard N.P., Gerard C. & Simon M.I. (1993) Specific interactions of chemoattractant factor receptors with G-proteins. J Biol Chem 268, 10139.
29. 29. El-Lati S.G., Dahinden C.A. & Church M.K. (1994) Complement peptides C3a-and C5a-induced mediator release from dissociated human skin mast cells. J Invest Dermatol 102, 803.
30. 30. Foxman E.F., Campbell J.J. & Butcher E.C. (1997) Multistep navigation and the combinatorial control of leukocyte chemotaxis. J Cell Biol 139, 1349.
31. 31. Dohlman H.G., Thorner J., Caron M.G. & Lefkowitz R.J. (1991) Model systems for the study of seven-transmembrane-segment receptors. Annu Rev Biochem 60, 653.
32. 32. Didsbury J.R., Uhing R.J., Tomhave E., Gerard C., Gerard N. & Snyderman R. (1991) Receptor class desensitization of leukocyte chemoattraclant receptors. Proc Natl Acad Sci USA 88, 11564.
33. 33. Tomhave E.D., Richardson R.M., Didsbury J.R., Menard L., Snyderman R. & Ali H. (1994) Cross-desensitization of receptors for peptide chemoattractants. Characterization of a new form of leukocyte regulation. J Immunol 153, 3267.
34. 34. Richardson R.M., Haribabu B., Ali H. & Snyderman R. (1996) Cross-desensitization among receptors for platelet-activating factor and peptide chemoattractants. J Biol Chem 271, 28717.
35. 35. Haines K.A., Kolasinski S.L., Cronstein B.N., Reibman -J., Gold L.I. & Weissman G. (1993) Chemoattraction of neutrophils by substance P and transforming growth factor-β1 is inadequately explained by current models of lipid remodeling. J Immunol 151, 1491.
36. 36. Konteatis Z.D., Siciliano S.J., Van Riper G. et al. (1994) Development of C5a receptor antagonists. Differential loss of functional responses. J Immunol 153, 4200.
37. 37. Yasui K., Yamazaki M., Miyabayashi M., Tsuno T. & Komiyama A. (1994) Signal transduction pathway in human polymorphonuclear leukocytes for chemotaxis induced by a chemotactic factor. Distinct from the pathway for superoxide anion production. J Immunol 152, 5922.